16 articles for J Tanaka
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis, resolution, and biological evaluation of atropisomeric (aR)- and (aS)-16-methyllamellarins N: unique effects of the axial chirality on the selectivity of protein kinases inhibition.
Nagasaki University
Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPAR¿ modulators.
Daiichi Sankyo
A prodrug approach towards the development of tricyclic-based FBPase inhibitors.
Daiichi Sankyo
Cyclotheonamide E4 and E5, new potent tryptase inhibitors from an Ircinia species of sponge.
Kirin Brewery
New guaianolides and xanthine oxidase inhibitory flavonols from ajania fruticulosa
Nanjing University
Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition.
Daiichi Sankyo
Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators.
Sanford Burnham Prebys Medical Discovery Institute
Structure-Activity Relationship Studies of 3- or 4-Pyridine Derivatives of DS-6930.
Daiichi Sankyo
S1319: a novel beta2-andrenoceptor agonist from a marine sponge Dysidea sp.
Kirin Brewery
Discovery of novel pyridazine derivatives as glucose transporter type 4 (GLUT4) translocation activators.
Daiichi Sankyo
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A.
Mcgill University
Discovery of DS-6930, a potent selective PPARĪ³ modulator. Part I: Lead identification.
Daiichi Sankyo
Discovery of DS-6930, a potent selective PPARĪ³ modulator. Part II: Lead optimization.
Daiichi Sankyo
Multi-targeted tyrosine kinase inhibitors and their pharmaceutical uses
Shanghai AB Pharmatech